Moderate riskFDA DrugClass II

Golden State Medical Supply carbamazepine recalled for black specks

Golden State Medical Supply is recalling Carbamazepine Tablets, USP 200mg due to black specks found in some tablets. This is a manufacturing quality issue. The affected lots were distributed nationwide.

From the FDA notice · Read the official notice ↗ · All Golden State Medical Supply recalls

What to do

  1. Check if you have one of the affected lot numbers: GS067429, GS068091, GS067430, or GS068090 (all expiring 5/31/2028)
  2. Contact your pharmacist or doctor if you have this medication
  3. Do not stop taking your carbamazepine without medical advice; your doctor can help you get unaffected tablets

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
1200 bottles
Illnesses reported
None reported
Manufactured in
5187 Camino Ruiz, Camarillo, CA, United States
Classification
Class II
Recall number
D-0771-2026

In the FDA's words

Description
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA CGMP deviations: tablets with black specks. Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028 Distribution: USA Nationwide Affected quantity: 1200 bottles
Hazard
CGMP deviations: tablets with black specks.

More from Golden State Medical Supply

See all

Related topics

OtherParticulateDrugsSold nationwideMore from FDA Drug